Perbedaan Indofarma Tbk. dan Total Bangun Persada Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Total Bangun Persada Tbk. diperdagangkan di Rp1.500 (kapitalisasi pasar 5,15 T, volume 24 jam 2,02 jt). Perbedaan utamanya: Total Bangun Persada Tbk. jauh lebih besar — sekitar 13,2× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | TOTL | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 5,15 T |
Volume | — | 2,02 jt |
Lot | — | 20,21 rb |
Perputaran | — | 3 M |
Harga Rata-rata | — | 1.485,19 |
Nilai Transaksi | — | 3 M |
Harga Ekuilibrium Indikatif | — | 1.500 |
Volume Ekuilibrium Indikatif | — | 482 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Total Bangun Persada (the company) was established under its original name of PT Tjahja Rimba Kentjana on Sep 4, 1970 then changed to PT Total Bangun Persada based on Notaries Deed dated Jul 24, 1981 and the deed of establishment was approved by the the Ministry of Justice dated Nov 4, 1981. The Company’s articles of association has been amended several times, most recently by notarial deed No. 47 of Haryanto, S.H., dated Oct 24, 2005, concerning the amendment of Company's authorized and paid up capital, and public offering.
Selengkapnya di halaman TOTL →